The BIOCHRONOMER brand, founded in 2001 (United States), from 4 sister brands and 2214 competing brands. The BIOCHRONOMER brand is owned by Heron Therapeutics, a company listed in New York. BIOCHRONOMER is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Heron Therapeutics
(BIOCHRONOMER)
over 5 years*
USD 0.31